BIO International Convention This Week June 27-30; News on AMGN,GILD
We will be attending the BIO Meeting in Washington DC and will not be posting as usual. Note that there were two news items over the weekend on our portfolio stocks: A positive article on Gilead (GILD) in Barron’s. Gilead Sciences Shares Could Rally – Barrons.com Another article in...
Wild Day on Wall Street: Did the RoboTraders Take Over?
Techs and Biotechs Turn Around Its up- its down- its way down -its coming back.At the end of the day NASDAQ recovered up 0.66% after being down more than 1.4%, the Dow was down 0.49% and the S&P down o.28%. Crosscurrents were too numerous to cover: plunge in oil from emergency release from...
MicroCaps Revisited: CONX, ICCC, IVD
Last December we reviewed three low market cap diagnostic stocks that had product revenue, deal or news potential and value. All are up from our last review and Immucell(ICCC $6.97) has appreciated 100% and still has a market cap of only $20M.Immucell is focused in the beef and dairy industries...
Second Big Rally Day Led by Materials, Technology and Energy: Healthcare Stocks Lag
The market touched the March lows last Friday , down for the year, and buyers swarmed in.Biotechs were strong yesterday buffering tech weakness and today the baton was passed to several sectors with a broad rally especially with NASDAQ up 2.23%. The NASDAQ-100 qqq was up 2.15%. Leaders were...
Biotech Stocks Lead NASDAQ-100 Rally:BIIB,CELG,GILD
NASDAQ stocks rallied today just off March 2011 QQQ bottoms led by large cap biotech stocks.The NASDAQ 100 is up 0.6% led by Biogen Idec(BIIB) up 4.26%, Celgene (CELG) up 3.27%, and Gilead (GILD) up 1.5%.The rally would be stronger were it not for weak tech stocks such as AAPL down 1.6% and...
